Casein kinase 2 from rat liver cytosol phosphorylated human fibrinogen in a reaction that was not stimulated by Ca2+ or cyclic AMP, but was markedly inhibited by heparin, and proceeded at a similar rate when either ATP or GTP was used as phosphate donor. Analysis of casein kinase 2 by glycerol-density-gradient centrifugation showed that the activities towards fibrinogen, casein, phosvitin, high-mobility-group protein 14 and glycogen synthase coincided. Maximal incorporation into fibrinogen by casein kinase 2 averaged 1 mol of phosphate/mol of protein substrate, most of it in the ac-chain, although some phosphorylation of the fl-chain was also detected. Analysis of phosphorylated a-chain revealed that most of the phosphate was incorporated on serine. Phosphorylation of human fibrinogen was also performed by casein kinase 2 from human polymorphonuclear leucocytes, lymphocytes and platelets.
INTRODUCTION
Human fibrinogen is an hexameric protein (a2x2y2) which contains phosphorus covalently bound at two or more locations in the a-chains (Doolittle et al., 1979) . The physiological role for the presence of phosphate in fibrinogen is not totally clear, but it seems to affect its clotting time (Blomback et al., 1963) . The synthesis of fibrinogen takes place in the liver, from where it is secreted to circulating blood. Studies on human fibrinogen (Blomback et al., 1972) and more recently on dog fibrinogen (Kudryk et al., 1982) have shown that the newly secreted fibrinogen is in the phosphorylated form, with phosphorylation occurring at a late secretory stage.
Several protein kinases have been shown to phosphorylate fibrinogen in vitro. These include the cyclic AMP-dependent protein kinase from pig muscle (Engstrom et al., 1980; Humble et al., 1981) , the Ca2+-activated phospholipid-dependent protein kinase from rat brain (Papanikolau et al., 1982) and pig spleen (Humble et al., 1984) , a human platelet kinase activity enhanced by interferon Krust et al., 1983) and rat liver cytosol casein kinase 1 , but no fibrinogen kinase activity seems to be present in human blood plasma (Humble etal., 1981) .
In addition to casein kinase 1, rat liver cytosol contains another casein kinase, designated casein kinase 2, different from the other in its molecular and catalytic properties . The presence of casein kinase 2 has also been detected in blood cells, such as human erythrocytes (Boivin & Galand, 1979) and pig polymorphonuclear leucocytes . In the present paper we show that casein kinase 2 from rat liver and human blood cells phosphorylates fibrinogen in a reaction that is not stimulated by cyclic AMP or Ca2+ but that is inhibited by heparin.
EXPERIMENTAL Materials
The source of all the reagents used in this work, including human fibrinogen and other protein substrates, was as previously reported Martos et al., 1985) .
Enzymes
Rat liver casein kinases 1 and 2 were purified as previously described (Martos et al., 1985) . The purified preparation of casein kinase 2 had a specific activity of about 90 units/mg of protein and contained only the Mr-41 000 and Mr-27 000 polypeptides present in casein kinases 2 purified from other sources (Hathaway & Traugh, 1982) .
Human polymorphonuclear leucocytes, lymphocytes and platelets were isolated from the blood of healthy donors by using standard techniques with minor modifications (Pena et al., 1983) . Casein kinase 2 was obtained from the different types of cells by chromatography on phosphocellulose and gel filtration on Bio-Gel A-1.5 m as described for the isolation of the protein kinases from pig polymorphonuclear leucocytes (Huang & Robinson, 1976; Itarte et al., 1983 Ames (1966) , except that the volumes were halved to increase sensitivity. Protein was determined by the method of Bradford (1976) and, for fibrinogen, also by its A282 (Blomback et al., 1972) .
Analysis of 32P-labeiled fibrinogen
Preparation of 32P-labelled fibrinogen phosphorylated by either casein kinase 1 or 2, analysis by polyacrylamidegel electrophoresis in the presence of 0.1 % SDS, and identification ofphosphoamino acids, were carried out as indicated previously .
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Vol. 234 Fig. 1(b) , was 2.8 mg/ml. This value is higher than those for casein, glycogen synthase and the high-mobility-group protein 14, which are in the range of 0.2-1 mg/ml (Martos et al., 1985) . The (Fig. 2) .
The phosphorylation of fibrinogen by casein kinase 2 was not stimulated by either cyclic AMP (20 /uM) or Ca2+ (0.5 mM), but was markedly inhibited by heparin (Fig. 3) when either ATP or GTP was used as phosphate donor, Top Fig. 2 . Analysis of casein kinase 2 by glycerol-density-gradient centrifugation A 0.1 ml portion of purified casein kinase 2 was layered over an 8-30% (v/v) glycerol density gradient (4.3 ml) and centrifuged at 55000 rev./min for 16 h at 4°C with an SW 60 rotor in a Beckman L8-70 centrifuge. Fractions (0.18 ml) were collected by piercing the bottom of the tube, and the protein kinase activity was assayed with [y-32P]ATP as phosphate donor and either in the absence (-) or in the presence of one of the following substrates; (0) casein (4 mg/ml), (A) phosvitin (4 mg/ml), (-) high-mobilitygroup protein 14 (0.4 mg/ml), (v) I-form glycogen synthase (0.2 mg/ml) or (y) fibrinogen (2 mg/ml). (Fig. 4) revealed that in both cases most of the phosphate was incorporated into the a-chain. However, casein kinase 2 also considerably phosphorylated the fl-chain, but not the y-chain, whereas casein kinase 1 slightly phosphorylated the y-chain.
Phosphoamino acid analysis of the a-chain of fibrinogen phosphorylated by casein kinase 2 showed that most ofthe phosphate was incorporated as phosphoserine, although some phosphothreonine, representing 10-15% of the total radioactivity, was also observed. Characteristics of casein kinase 2 from hmnan blood cells The properties of the casein kinases 2 purified from human polymorphonuclear leucocytes, lymphocytes and platelets, such as their apparent Mr (150000), apparent Km for casein (0.8 mg/ml), ATP (15 /M) and GTP (22 #M), as well as their stimulation by Mg2+ (Ka 1.5 mM), were very similar, and resemble those reported for casein kinase II from erythroid cells (Hathaway & Traugh, 1982; Boivin & Galand, 1979) , casein kinase 2 from rat liver cytosol and other type II casein kinases present in different mammalian tissues (Hathaway & Traugh, 1982) .
All these human blood-oell casein kinases 2 phosphorylated human fibrinogen; the rate of the reaction depended on the amount of casein kinase present, and the maximal Fig. 4 . Analysis of phosphorylated fibrinogen by slab-gel electrophoresis Samples of fibrinogen phosphorylated by either casein kinase 1 (CK-1) or casein kinase 2 (CK-2) were subjected to electrophoresis in a 7-16% -polyacrylamide-gradient slab gel containing 0.1 % SDS and then autoradiographed. The activity of casein kinase 2 from human lymphocytes and platelets on fibrinogen (2.6 mg/ml) was assayed in the presence of the indicated compounds. Values are expressed as percentages of the activity determined with ATP as phosphate donor, without additions. Influence of phosphorylation on the clotting time of fibrinogen Years ago it was suggested that, although the presence of phosphate in human fibrinogen was not a requirement for clotting, dephosphorylation of fibrinogen by alkaline phosphatase increased its clotting time moderately (Blomback et al., 1963) .
When the clotting time for samples of fibrinogen (1.6 mg/ml), control or phosphorylated by rat liver cytosol casein kinase 1 or casein kinase 2, was determined, values of 31+1, 31+2 and 32+2s were obtained respectively, indicating no significant change in this parameter by phosphorylation.
DISCUSSION
The possible role of casein kinase 2 in the control of physiological processes has gained considerable support in recent years owing to the evidence that this enzyme phosphorylates in vitro several biologically important proteins such as glycogen synthase (Huang et al., 1982) , the regulatory subunit of type II cyclic AMP-dependent protein kinase (Carmichael et al., 1982) and high-mobilitygroup protein 14 (Walton & Gill, 1983) . Furthermore, the phosphorylation of these substrates has been shown to take place at the same site(s) that are phosphorylated in vivo under different physiological conditions (Parker et al., 1982; Carmichael et al., 1982; Walton & Gill, 1983) . The data obtained here on the co-migration of activities on glycerol-density-gradient centrifugation, together with the ability to use GTP as phosphate donor and the strong inhibition by heparin, clearly show that fibrinogen is also a substrate for casein kinase 2.
The maximal phosphorylation of fibrinogen achieved by casein kinase 2 is lower than that by casein kinase 1, the cyclic AMP-dependent protein kinase (Engstrom et al., 1980) or the Ca2+-activated phospholipid-dependent protein kinase (Humble et al., 1984) . The Km for fibrinogen of casein kinase 2 (2.8 mg/ml) is higher than that of the Ca2+-activated phospholipid-dependent protein kinase (0.1-0.2 mg/ml, determined at pH 6.5) (Humble et al., 1984) , but lower than those of casein kinase 1 (11.3 mg/ml) ) and the cyclic AMP-dependent protein kinase (> 8 mg/ml) (Engstrom et al., 1980) . If the data on the concentrations of these protein kinases in liver cells (Kuo et al., 1980; Martos et al., 1985) and their activity on fibrinogen relative to the preferred substrates histone or casein in the pH 7.0-7.5 range (Engstrom et al., 1980; Itarte et al., 1983; Humble et al., 1984 ; the present paper) are taken together, their concentration as fibrinogen kinases (at 2 mg of fibrinogen/ml) will be approx. 0.05 unit/ml for the cyclic AMP-dependent protein kinase, 0.2 unit/ml for the Ca2+-activated phospholipid-dependent protein kinase, 0.32 unit/ml for casein kinase 1 and 0.15 unit/ml for casein kinase 2.
Phosphorylation of fibrinogen may affect at least two processes in which this protein is involved. One is the clotting time, as pointed out by Blomback et al. (1963) . In this regard, the data obtained here indicate that phosphorylation by either casein kinase 1 or casein kinase 2 does not seem to alter the coagulability of fibrinogen. To our knowledge, no data are available on the possible effect of phosphorylation by other protein kinases on this parameter. Phosphorylation also seems to be related to the secretion of fibrinogen into the circulating blood. The presence of casein kinase 2 in the liver, whence fibrinogen is secreted in a phosphorylated form (Kudryk et al., 1982) , suggests that the potential involvement of this enzyme in fibrinogen phosphorylation cannot be disregarded.
